SHPAX
Price
$19.13
Change
+$0.23 (+1.22%)
Updated
Jun 24 closing price
Net Assets
9.98M
THISX
Price
$77.30
Change
+$1.17 (+1.54%)
Updated
Jun 24 closing price
Net Assets
11.16B
Interact to see
Advertisement

SHPAX vs THISX

Header iconSHPAX vs THISX Comparison
Open Charts SHPAX vs THISXBanner chart's image
Saratoga Health & Biotechnology A
Price$19.13
Change+$0.23 (+1.22%)
VolumeN/A
Net Assets9.98M
T. Rowe Price Health Sciences I
Price$77.30
Change+$1.17 (+1.54%)
VolumeN/A
Net Assets11.16B
SHPAX vs THISX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SHPAX vs. THISX commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SHPAX is a Buy and THISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
THISX has more cash in the bank: 11.2B vs. SHPAX (9.98M). THISX pays higher dividends than SHPAX: THISX (0.19) vs SHPAX (0.00). SHPAX was incepted earlier than THISX: SHPAX (26 years) vs THISX (9 years). SHPAX (2.72) is less costly to investors than THISX (0.67). THISX is a more actively managed with annual turnover of: 52.40 vs. SHPAX (17.00). SHPAX has a lower initial minimum investment than THISX: SHPAX (250) vs THISX (500000). SHPAX annual gain was more profitable for investors over the last year : -6.90 vs. THISX (-20.03). SHPAX return over 5 years is better than : -3.72 vs. THISX (-12.43).
SHPAXTHISXSHPAX / THISX
Total Expense Ratio2.720.67406%
Annual Report Gross Expense Ratio2.720.67406%
Fund Existence26 years9 years-
Gain YTD0.585-4.491-13%
Front Load6%N/A-
Min. Initial Investment2505000000%
Min. Initial Investment IRAN/AN/A-
Net Assets9.98M11.2B0%
Annual Yield % from dividends0.000.19-
Returns for 1 year-6.90-20.0334%
Returns for 3 years-4.55-11.9838%
Returns for 5 years-3.72-12.4330%
Returns for 10 years-41.07N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDERX22.640.01
+0.06%
Federated Hermes Equity Income R
GQLOX33.90N/A
N/A
GMO Quality VI
MDOEX11.02N/A
N/A
Morgan Stanley Developing Opportunity I
UGLSX75.03N/A
N/A
JHancock U.S. Global Leaders Growth R6
MSCFX27.48N/A
N/A
Mairs & Power Small Cap